Digital Health Technologies in Pediatric Trials

Assessing Infant Gross Motor Performance With an At-Home Wearable

BACKGROUND

Early development of gross motor skills is foundational for the upcoming neurocognitive performance. Here, we studied whether at-home wearable measurements performed by the parents could be used to quantify and track infants' developing motor abilities.

METHODS

Unsupervised at-home measurements of the infants' spontaneous activity were made repeatedly by the parents using a multisensor wearable suit (altogether 620 measurements from 134 infants at age 4-22 months). Machine learning-based algorithms were developed to detect the reaching of gross motor milestones (GMM), to measure times spent in key postures, and to track the overall motor development longitudinally. Parental questionnaires regarding GMMs were used for developing the algorithms, and the results were benchmarked with the interrater agreement levels established by World Health Organization (WHO). A total of 97 infants were used for the algorithm development and cross-validation, whereas an external validation was done using 37 infants from an independent recruitment in the same hospital.

RESULTS

The algorithms detected the reaching of GMMs very accurately (cross-validation: accuracy, 90.9%-95.5%; external validation, 92.4%-96.8%), which compares well with the human experts in the WHO reference study. The wearable-derived postural times showed strong correlation to parental assessments (ρ = .48-.81). Individual trajectories of motor maturation showed strong correlation to infants' age (ρ = .93).

CONCLUSIONS

These findings suggest that infants' gross motor skills can be quantified reliably and automatically from unsupervised at-home wearable recordings. Such methodology could be used in health care practice and in all developmental studies for gaining real-world quantitation and tracking of infants' motor abilities.

Clinical Nurses' Identification of a Wearable Universal Serial Bus Used for Pediatric Oncology Clinical Trial Participant Safety Management

The expanded access to clinical trials has provided more patients the opportunity to participate in novel therapeutics research. There is an increased likelihood of a patient, as a pediatric oncology clinical trial participant, to present for clinical care outside the research site, such as at an emergency room or urgent care center. A novel wearable universal serial bus device is a proposed technology to bridge potential communication gaps, pertaining to critical information such as side effects and permitted therapies, between research teams and clinical teams where investigational agents may be contraindicated to standard treatments. Fifty-five emergency and urgent care nurses across the United States were presented, via online survey without priming to the context of clinical trials or the device, a picture of a pediatric patient wearing the novel wearable device prompted to identify significant, environmental cues important for patient care. Of the 40 nurses observing the patient photo, three identified the wearable device within Situational Awareness Global Assessment Tool formatted narrative response fields. Analysis of the narrative nurse-participant responses of significant clinical findings upon initial assessment of the pediatric patient photo is described, as well as the implications for subsequent prototyping of the novel universal serial bus prototype.